NEUP
Neuphoria Therapeutics Inc.
Supply chain · Ownership · Earnings
Neuphoria Therapeutics Inc.
Supply chain · Ownership · Earnings
Nasdaq · Pharmaceutical Preparations
High 3.49 3:15 pm · Low 3.49 3:15 pm ET
Sources
sec edgar · verbatim disclosure“During the twelve months ended June 30, 2026, the Company paid Danforth a total of $843,714, of which $325,894 was for the service of Mr. Cunningham as our CFO.”
“On April 30, 2024, the Company appointed Wolf & Company, P.C. as our independent registered public accounting firm for U.S. reporting purposes beginning with the fiscal year ended June 30, 2024.”
“On March 19, 2025, we received a $15.0 million milestone payment after Merck initiated the Phase 2 trial of MK-1167 (NCT06721156).”
“On October 30, 2024, Carina made a milestone payment to the Company in the gross amount of A$1,000,000 which was recorded as revenue in the Consolidated Statement of Operations and Other Comprehensive Income (Loss) during the twelve months ended June 30, 2025, included in this Form 10-K.”
“During the twelve months ended June 30, 2026 and 2025, WG Partners invoiced the Company for monthly stipend fees of $219,981 and $148,971, respectively.”
“Our revenue decreased during the twelve months ended June 30, 2026, as compared to the same period ended 2025, primarily due to the non-recurring $15.0 million licensing milestone payment received from the Merck Agreement during the twelve months ended June 30, 2025, as compared to the $1.2 million in revenue received from our CTx CRC collaboration agreement during the twelve months ended June 30, 2026.”
Neuphoria Therapeutics Inc. has 3 disclosed suppliers and 3 disclosed customers in SEC filings.
3 disclosed: Danforth Advisors LLC, Wolf & Company, P.C. and WG Partners LLP.
3 disclosed: Merck & Co., Inc., Carina Biotech and Cancer Therapeutics Cooperative Research Centre (CTx CRC); 1 is a partnership or agreement.
NEUP (Neuphoria Therapeutics Inc.) has 3 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Distance from centre = disclosure strength · Extended: 2nd-degree ties, single companies only